Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7388 p191
18 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Concerns over oxygen service continue to be raised

In response to the failures of the new home oxygen service, an action checklist has been drawn up by the Department of Health, the NHS and the new suppliers, but problems with the transfer of the service have continued to be raised.

The checklist states that GPs should continue to issue FP10s to patients requiring cylinder oxygen and that pharmacy contractors who supply against an FP10 prescription will be paid until the patient transfers to a new supplier. The guidance is available online.

Difficulties with the introduction of the new service have continued to be highlighted this week, however. One pharmacist complained to The Journal that Allied Respiratory had told patients that it could not cope and that patients should dial 999 for help.

Steve Gullick, managing director of Allied Respiratory, told The Journal: “Last week we received in excess of 24,000 calls from existing cylinder patients but, due to the inaccurate information given to us by GPs, the contract was unserviceable. However, at no point did we suggest that patients call 999.”

The chaotic start of the new contracts has also been described in several Letters to The Journal (p204) and pharmacists have complained that they have been unable to contact Air Products via its helpline. A spokesman for Air Products told The Journal: “There were certainly difficulties last week and we apologise to those patients and pharmacists who could not get through. Along with the health authorities, we planned for around 3,000 calls a day to our helpline — more than 10 times the number you would expect during normal operations. In the first two days, 12,500 calls were made to our helpline. The company responded quickly to the volume of calls and put in place more than three times the levels of resource.”

Another pharmacist writes that the wife of a patient receiving oxygen was told by BOC Vitalair that, in order to find information about the new service, she should visit her local library to use the internet. A spokesman for BOC told The Journal: “The Vitalair internet forms a part of BOC’s communications to patients about the new home care oxygen arrangements. Over the last few months BOC has written to all patients, enclosing an explanatory letter from their local primary care trust and a BOC brochure about the new service. … In addition, patients receive a comprehensive booklet from BOC when they are first supplied with oxygen by BOC.” He also explained BOC’s delivery policy following concerns that delivery days and times would be limited. “If a patient needs oxygen to be delivered every day then BOC will deliver every day,” he said.

Disagreement has continued as to whether the present phased transition was intended. Before the transfer, Primary Care Contracting’s communications team said: “After 1 February we expect pharmacists to withdraw progressively from the provision of cylinder services. … We expect all pharmacists to continue to provide a cylinder service within the validity of the prescription.”

Air Products told The Journal this week: “A transition period to the new service was always planned where pharmacies could continue to supply oxygen to patients until they were transferred to the new service.”

The Pharmaceutical Service Negotiating Committee said in a statement last week: “Although it was not the Department of Health’s intention, where oxygen is required and the surgery cannot contact the new supplier, pharmacies will be reimbursed for dispensing prescriptions dated after 1 February.”

Back to Top


©The Pharmaceutical Journal